MARKET

TEVA

TEVA

Teva Pharm
NYSE
17.10
+0.30
+1.79%
After Hours: 17.15 +0.05 +0.29% 18:27 07/26 EDT
OPEN
16.93
PREV CLOSE
16.80
HIGH
17.24
LOW
16.86
VOLUME
9.09M
TURNOVER
0
52 WEEK HIGH
17.69
52 WEEK LOW
8.06
MARKET CAP
19.37B
P/E (TTM)
-38.8283
1D
5D
1M
3M
1Y
5Y
1D
Teva's Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs
Teva Pharmaceutical's stock is up 69% since December. Recent developments include the launch of biosimilars and generics. Teva's current ratio is under 1, with upcoming debt maturities posing a challenge. Recommendation remains "Hold" pending Q2 earnings.
Seeking Alpha · 14h ago
Sanofi (SNY) Q2 Earnings Beat, Sales Miss, 2024 View Raised
NASDAQ · 1d ago
Teva And Sanofi Fast-Track Anti-TL1A Phase 2b Trial For Inflammatory Bowel Disease
Benzinga · 1d ago
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
Teva and Sanofi are collaborating to co-develop and co-commercialize duvakitug for moderate-to-severe ulcerative colitis and crohn's disease. The RELIEVE UCCD Phase 2b trial has completed early due to significant acceleration in patient recruitment. Teva and sanofi now anticipate having topline results for both UC and CD in Q4 2024.
Barchart · 2d ago
Piper Sandler Remains a Buy on Teva Pharmaceutical (TEVA)
TipRanks · 2d ago
Teva Pharmaceutical: Hold Rating Amidst Steady Quarter Performance and Market Uncertainties
TipRanks · 2d ago
Why Hims & Hers Heath Shares Are Surging Today
Hims & Hers Health Inc. Appointed former Novo Nordisk COO and President Kåre Schultz to its Board of Directors. Schultz was instrumental in establishing the company as a leader in diabetes care. Schultz brings extensive experience from his leadership roles at Lundbeck and Teva Pharmaceutical Industries.
Benzinga · 4d ago
Court weighs what US must prove in Regeneron kickback case
U.S. Department of Justice wants appeals court to overturn judge's ruling in kickback case against drugmaker. The Justice Department accused Regeneron Pharmaceuticals of using a charity to pay kickbacks to pay for drugs. The drugmaker denies the allegations. The government says the ruling makes it harder to hold companies accountable for paying kickbacks.
Reuters · 4d ago
More
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Webull offers Teva Pharmaceutical Industries Ltd (ADR) stock information, including NYSE: TEVA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TEVA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TEVA stock methods without spending real money on the virtual paper trading platform.